Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

3-D Printing Process Developed for Living Tissue

Researchers in the U.K. devised 3-D printing techniques for human and animal cells to produce functioning tissue with multiple types of cells. . . . → Read More: 3-D Printing Process Developed for Living Tissue

Parkinson’s Protein Experiment in Space Station Cargo

An experiment to grow a crystallized form of protein associated with Parkinson’s disease is among the cargo that lifted off today from NASA’s Kennedy Space Center. . . . → Read More: Parkinson’s Protein Experiment in Space Station Cargo

Patent Set for Peptide Nerve Damage Treatments

The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4. . . . → Read More: Patent Set for Peptide Nerve Damage Treatments

Viruses Removed from Pig Organs for Human Transplants

Researchers in the U.S., Denmark, and China devised a process with genome editing to remove viruses that prevent organs from pigs from being used for human transplants. . . . → Read More: Viruses Removed from Pig Organs for Human Transplants

Peptide Immunotherapy Shown Safe for Type 1 Diabetes

In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes

Study Underway of Depression, Bipolar Disorder Genetics

A large-scale study by two companies and a think tank started enrolling participants to learn more about the role of genetics in major depressive and bipolar disorders. . . . → Read More: Study Underway of Depression, Bipolar Disorder Genetics

University, Company Employ AI for Anti-Aging Drugs

The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging. . . . → Read More: University, Company Employ AI for Anti-Aging Drugs

RNA Vaccine for Rabies Found Safe, Generates Antibodies

A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies. . . . → Read More: RNA Vaccine for Rabies Found Safe, Generates Antibodies

Faster Process Devised for Targeted Antibodies

Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies. . . . → Read More: Faster Process Devised for Targeted Antibodies